Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1887907 | 1.00 | TSHR (0.39) | TSHRTHRBALDH1A1 | |
| SCHEMBL14208681 | 1.00 | TSHR (0.39) | TSHRTHRBALDH1A1 | |
| SCHEMBL1888838 | 0.98 | TSHR (0.40) | TSHRTHRBALDH1A1 | |
| SCHEMBL14208609 | 0.95 | TSHR (0.40) | TSHRTHRBALDH1A1 | |
| SCHEMBL248332 | 0.93 | TSHR (0.44) | TSHRTHRBALDH1A1 | |
| SCHEMBL246497 | 0.93 | TSHR (0.44) | TSHRTHRBALDH1A1 | |
| SCHEMBL248056 | 0.93 | TSHR (0.44) | TSHRTHRBALDH1A1 | |
| SCHEMBL246347 | 0.93 | TSHR (0.44) | TSHRTHRBALDH1A1 | |
| SCHEMBL248380 | 0.93 | TSHR (0.44) | TSHRTHRBALDH1A1 | |
| SCHEMBL247163 | 0.93 | TSHR (0.44) | TSHRTHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170322488-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR RESIN FILM, PRODUCTION METHOD FOR ORGANIC SEMICONDUCTOR ELEMENT, AND FLUORINE-CONTAINING POLYMER | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-11-09 | — | — | US | disclosed |
| EP-1510197-B1 | Dental coating material | IVOCLAR VIVADENT AG (LI) | 2016-03-09 | — | — | EP | disclosed |
| EP-1732499-B1 | HARDENING DENTAL MATERIALS FEATURING ADJUSTABLE TRANSLUCENCE | IVOCLAR VIVADENT AG (LI) | 2014-03-05 | — | — | EP | disclosed |
| US-7939682-B2 | Fluorine-containing adamantane derivative, fluorine-containing adamantane derivative having polymerizable group, and resin composition containing same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-05-10 | — | — | US | disclosed |
| US-20090149665-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, AND RESIN COMPOSITION CONTAINING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20090099326-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-2014639-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | Idemitsu Kosan Co., Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |
| US-20080319104-A1 | Hardening Dental Materials Featuring Adjustable Translucence | IVOCLAR VIVADENT AG (LI) | 2008-12-25 | — | — | US | disclosed |
| EP-1732499-A1 | HARDENING DENTAL MATERIALS FEATURING ADJUSTABLE TRANSLUCENCE | Ivoclar Vivadent AG (LI) | 2006-12-20 | — | — | EP | disclosed |
| WO-2005097043-A1 | HARDENING DENTAL MATERIALS FEATURING ADJUSTABLE TRANSLUCENCE | IVOCLAR VIVADENT AG (DE) | 2005-10-20 | — | — | WO | disclosed |
| EP-1510197-A1 | Dental coating material | Firma Ivoclar Vivadent AG (LI) | 2005-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099326-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND ANTIREFLECTION FILM | ADGRF1, RFT1, AFF1 | TSHR 958/4885THRB 2864/4885ALDH1A1 282/4885 |
| US-20090149665-A1 | FLUORINE-CONTAINING ADAMANTANE DERIVATIVE, FLUORINE-CONTAINING ADAMANTANE DERIVATIVE HAVING POLYMERIZABLE GROUP, AND RESIN COMPOSITION CONTAINING SAME | TAS1R1, ADORA1, TAS2R1 | TSHR 1786/4885THRB 2526/4885ALDH1A1 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.